Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Vibratory Stimulation to Improve Balance Recovery

Official title: Subsensory Stochastic Vibratory Stimulation to Assess and Improve Aging Related Proprioceptive Deficits Associated With Balance Recovery

Run by Rutgers, The State University of New Jersey · NCT05702801 · Data updated 2026-11-12

Researchers will test whether stochastic vibratory stimulation can help older adults with proprioceptive deficits recover balance after a trip.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment60 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Locations1 site (Newark, New Jersey)
StatusRecruiting
StartedMay 1, 2024
Main results expectedSeptember 1, 2028
Study endsSeptember 1, 2029
Registry record updatedJuly 8, 2026
Trial IDNCT05702801 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 65 years or older who can understand study instructions and do not have major motor, balance, or neurovestibular disorders that would confound testing.

Probably not a fit

Individuals with severe motor or balance impairments, significant cognitive impairment, or unmanaged vestibular disorders may not benefit from SVS and may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates stochastic vibratory stimulation (SVS) as a method to improve proprioception and balance recovery in adults aged 65 and older who are at high risk of falls. Participants will be divided into low and high fall-risk groups and undergo proprioceptive assessments, balance tests, and treadmill perturbations, with and without SVS. The study uses safety platforms and standardized questionnaires to evaluate functional balance, fear of falling, cognition, comorbidity, mood, pain, and vestibular symptoms. The goal is to determine if SVS can modulate muscle spindle activation and enhance balance recovery from tripping in older adults with proprioceptive deficits.

Why it matters

Potential benefit: If successful, SVS could become a non-invasive approach to reduce fall risk and improve balance recovery in older adults with proprioceptive deficits.

How similar studies have gone: Prior work suggested promising balance and TUG improvements with SVS in high fall risk older adults, but results in this specific proprioceptive deficit population are exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age 65 years or older
* the ability to understand study instructions.

Exclusion Criteria:

* disorders associated with severe motor and balance deficits, including stroke, Parkinson's disease, severe arthritis, lower-extremity amputation, spinal cord pathologies (e.g., spinal stenosis), and diabetes
* history of severe vestibular disorder such as bilateral vestibular hypofunction or poorly-compensated unilateral vestibular hypofunction, or Dizziness Handicap Inventory (DHI) \> 40
* central nervous disease
* cognitive impairment (MoCA score\<20)
* vision problems including cataract, presbyopia, and similar problems that can influence balance
* sedating medication or alcohol consumption within 24 hours.

Where it's running

  • Rutgers, State University of New Jersey
    Newark, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.